Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Ross, Ellison"'
Autor:
Danny V. Lam, Justin Chin, Meagan K. Brucker-Hahn, Megan Settell, Ben Romanauski, Nishant Verma, Aniruddha Upadhye, Ashlesha Deshmukh, Aaron Skubal, Yuichiro Nishiyama, Jian Hao, J. Luis Lujan, Simeng Zhang, Bruce Knudsen, Stephan Blanz, Scott F. Lempka, Kip A. Ludwig, Andrew J. Shoffstall, Hyun-Joo Park, Erika Ross Ellison, Mingming Zhang, Igor Lavrov
Publikováno v:
Bioelectronic Medicine, Vol 10, Iss 1, Pp 1-16 (2024)
Abstract Background Spinal cord stimulation (SCS) has demonstrated multiple benefits in treating chronic pain and other clinical disorders related to sensorimotor dysfunctions. However, the underlying mechanisms are still not fully understood, includ
Externí odkaz:
https://doaj.org/article/b5b48affe6404089aa5540dfcae13e93
Autor:
Danny V. Lam, Justin Chin, Meagan K. Brucker-Hahn, Megan Settell, Ben Romanauski, Nishant Verma, Aniruddha Upadhye, Ashlesha Deshmukh, Aaron Skubal, Yuichiro Nishiyama, Jian Hao, J. Luis Lujan, Simeng Zhang, Bruce Knudsen, Stephan Blanz, Scott F. Lempka, Kip A. Ludwig, Andrew J. Shoffstall, Hyun-Joo Park, Erika Ross Ellison, Mingming Zhang, Igor Lavrov
Publikováno v:
Bioelectronic Medicine, Vol 10, Iss 1, Pp 1-2 (2024)
Externí odkaz:
https://doaj.org/article/cef35d49ca7b4946986e940d232ee9e8
Autor:
Eric Sparkes, Rochelle Boyd, Shuli Chen, Jack W. Markham, Jia Lin Luo, Tahira Foyzun, Humayra Zaman, Charlotte Fletcher, Ross Ellison, Iain S. McGregor, Marina J. Santiago, Felcia Lai, Roy R. Gerona, Mark Connor, David E. Hibbs, Elizabeth A. Cairns, Michelle Glass, Adam Ametovski, Samuel D. Banister
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Synthetic cannabinoid receptor agonists (SCRAs) continue to make up a significant portion new psychoactive substances (NPS) detected and seized worldwide. Due to their often potent activation of central cannabinoid receptors in vivo, use of SCRAs can
Externí odkaz:
https://doaj.org/article/8bb387539a3c4fa38d68649acedf0eb4
Autor:
Kerollos Shaker, Andrea Nillas, Ross Ellison, Kelsey Martin, Jordan Trecki, Roy Gerona, Kim Aldy
Publikováno v:
Journal of Medical Toxicology. 19:190-195
Autor:
Ashley J. Choe, Ross Ellison, Sunil R. Ramaswamy, Rachel F. Schult, Roy Gerona, Nicholas Nacca
Publikováno v:
The Journal of Emergency Medicine. 64:259-262
Autor:
Richard C. Kevin, Somayeh Mirlohi, Jamie J. Manning, Rochelle Boyd, Elizabeth A. Cairns, Adam Ametovski, Felcia Lai, Jia Lin Luo, William Jorgensen, Ross Ellison, Roy R. Gerona, David E. Hibbs, Iain S. McGregor, Michelle Glass, Mark Connor, Chris Bladen, Gerald W. Zamponi, Samuel D. Banister
Publikováno v:
ACS Chemical Neuroscience. 13:1395-1409
Autor:
Roy Gerona, Michelle Glass, Marie Deventer, Rochelle Boyd, Shuli Chen, Felcia Lai, Ross Ellison, Lewis J. Martin, Elizabeth A. Cairns, David E. Hibbs, Katharina Elisabeth Grafinger, Eric Sparkes, V. Auwaerter, Samuel D. Banister, Richard C. Kevin, Iain S. McGregor, Christophe P. Stove
Publikováno v:
RSC Med Chem
Synthetic cannabinoid receptor agonists (SCRAs) remain one the most prevalent classes of new psychoactive substances (NPS) worldwide, and examples are generally poorly characterised at the time of first detection. We have synthesised a systematic lib
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:153-155
Autor:
Katharina Elisabeth Grafinger, Volker Auwärter, Samuel D. Banister, Christophe P. Stove, Annelies Cannaert, Ross Ellison, Roy Gerona, Eric Sparkes, Adam Ametovski, Elizabeth A. Cairns, Jia Lin Luo, Edward Pike
Publikováno v:
Drug Testing and Analysis. 13:1383-1401
Synthetic cannabinoid receptor agonists (SCRAs) are one of the largest and most structurally diverse classes of new psychoactive substances (NPS). Despite this, pharmacological data are often lacking following the identification of a new SCRA in drug
Autor:
Edward Pike, Richard C. Kevin, Roy Gerona, Ada Fang, Annelies Cannaert, Jia Lin Luo, Christophe P. Stove, Eric Sparkes, Ross Ellison, Samuel D. Banister
Publikováno v:
ACS Chemical Neuroscience. 11:4434-4446
Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid pace at which these drugs enter the market, there is often little or n